
ABCL Valuation
Abcellera Biologics Inc
- Overview
- Forecast
- Valuation
- Earnings
ABCL Relative Valuation
ABCL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABCL is overvalued; if below, it's undervalued.
Historical Valuation
Abcellera Biologics Inc (ABCL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 30.78 is considered Undervalued compared with the five-year average of 12.24. The fair price of Abcellera Biologics Inc (ABCL) is between 1209.54 to 1214.08 according to relative valuation methord. Compared to the current price of 5.15 USD , Abcellera Biologics Inc is Undervalued By 99.57%.
Relative Value
Fair Zone
1209.54-1214.08
Current Price:5.15
99.57%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.46
P/B
Median3y
1.38
Median5y
14.28
-9.32
FCF Yield
Median3y
-8.67
Median5y
-4.09
Competitors Valuation Multiple
The average P/S ratio for ABCL's competitors is 31388.53, providing a benchmark for relative valuation. Abcellera Biologics Inc Corp (ABCL) exhibits a P/S ratio of 35.39, which is -99.89% above the industry average. Given its robust revenue growth of -57.45%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

MRNO
Murano Global Investments Plc
8.047
USD
+3.70%

CBL
CBL & Associates Properties Inc
27.420
USD
+2.31%

UVSP
Univest Financial Corp
31.900
USD
+0.13%

ASTL
Algoma Steel Group Inc
6.920
USD
-0.14%

ATLC
Atlanticus Holdings Corp
51.900
USD
+0.46%

BORR
Borr Drilling Ltd
2.000
USD
+7.53%

SXC
SunCoke Energy Inc
8.720
USD
+2.59%

CRSR
Corsair Gaming Inc
9.315
USD
+1.03%

PTLO
Portillos Inc
11.460
USD
+5.33%

INDI
indie Semiconductor Inc
4.300
USD
-2.49%
FAQ

Is Abcellera Biologics Inc (ABCL) currently overvalued or undervalued?
Abcellera Biologics Inc (ABCL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 30.78 is considered Undervalued compared with the five-year average of 12.24. The fair price of Abcellera Biologics Inc (ABCL) is between 1209.54 to 1214.08 according to relative valuation methord. Compared to the current price of 5.15 USD , Abcellera Biologics Inc is Undervalued By 99.57% .

What is Abcellera Biologics Inc (ABCL) fair value?

How does ABCL's valuation metrics compare to the industry average?

What is the current P/B ratio for Abcellera Biologics Inc (ABCL) as of Jul 23 2025?

What is the current FCF Yield for Abcellera Biologics Inc (ABCL) as of Jul 23 2025?

What is the current Forward P/E ratio for Abcellera Biologics Inc (ABCL) as of Jul 23 2025?
